Abera Bioscience AB announced that it will issue 1,114,363 shares at a price of SEK 15.30 per share for gross proceeds of SEK 17,000,000 in a round of funding on June 9, 2021. The transaction will include participation from a group of existing and external qualified investors. The transaction has been approved by the board of directors of the company at its Annual General Meeting.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.8 SEK | -12.41% | +6.67% | -6.98% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.98% | 6.81M | |
+29.61% | 49.18B | |
+0.80% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.66% | 26.09B | |
-22.76% | 18.71B | |
+8.46% | 13.26B | |
+32.20% | 12.32B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- ABERA Stock
- News Abera Bioscience AB
- Abera Bioscience AB announced that it expects to receive SEK 17.049754 million in funding